OTCMKTS:CWBR
CohBar Inc Stock News
$0.80
+0 (+0%)
At Close: May 03, 2024
Why Is CohBar (CWBR) Stock Up 130% Today?
11:44am, Tuesday, 23'rd May 2023
CohBar (NASDAQ: CWBR ) stock is soaring higher on Tuesday after the company announced a planned merger with Morphogenesis . CohBar and Morphogenesis are planning for an all-stock merger that will see
CohBar to Announce 2022 Third Quarter Financial Results and Provide Business Update on November 8, 2022
09:00am, Wednesday, 26'th Oct 2022
Company to host conference call and webcast at 5:00 p.m. ET Company to host conference call and webcast at 5:00 p.m. ET
Cohbar Inc. (CWBR) Upgraded to Strong Buy: What Does It Mean for the Stock?
01:33pm, Friday, 21'st Oct 2022
Cohbar Inc. (CWBR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
7 Nasdaq Stocks to Sell Before They Die
06:21pm, Monday, 26'th Sep 2022
As is typical of a bear market, the Nasdaq has led the other major indices lower over the past year. The tech-heavy index is down 28% over the past 12 months compared with a 17% decline in the S&P 500
CohBar (CWBR) Stock: 1-For-30 Reverse Split Goes Into Effect
08:35am, Friday, 23'rd Sep 2022
A 1-for-30 reverse split of CohBar (CWBR) stock has gone into effect today. These are the details.
CohBar to Present at H.C. Wainwright 24th Annual Global Investment Conference
09:00am, Tuesday, 06'th Sep 2022
MENLO PARK, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company exploiting the power of the mitochondria and the peptides encoded in its geno
CohBar, Inc. (CWBR) CEO Joe Sarret on Q2 2022 Results - Earnings Call Transcript
08:11pm, Monday, 15'th Aug 2022
CohBar, Inc. (NASDAQ:CWBR ) Q2 2022 Earnings Conference Call August 15, 2022 5:00 PM ET Company Participants Jordyn Tarazi - Director of IR Joe Sarret - CEO Jeff Biunno - CFO Nick Vlahakis - Acting CM
CohBar to Announce 2022 Second Quarter Financial Results and Provide Business Update on August 15, 2022
09:00am, Monday, 01'st Aug 2022
Company to host conference call and webcast at 5:00 p.m. ET Company to host conference call and webcast at 5:00 p.m. ET
CohBar to Present at the H.C. Wainwright Global Investment Conference
04:02pm, Thursday, 19'th May 2022
MENLO PARK, Calif., May 19, 2022 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company leveraging the power of the mitochondria and the peptides encoded in its genome
CohBar Inc. (CWBR) CEO Joe Sarret on Q1 2022 Results - Earnings Call Transcript
09:20pm, Monday, 16'th May 2022
CohBar Inc. (NASDAQ:CWBR ) Q1 2022 Results Conference Call May 16, 2022 5:00 PM ET Company Participants Joe Sarret - CEO Jeff Biunno - CFO Nick Vlahakis - Acting CMO Kent Grindstaff - SVP, Research Co
CohBar to Announce 2022 First Quarter Financial Results and Provide Business Update on May 16, 2022
09:00am, Monday, 02'nd May 2022
Company to host conference call and webcast at 5:00 p.m. ET Company to host conference call and webcast at 5:00 p.m. ET
CohBar, Inc. (CWBR) CEO Joe Sarret on Q4 2021 Results - Earnings Call Transcript
10:44pm, Tuesday, 29'th Mar 2022
CohBar, Inc. (CWBR) CEO Joe Sarret on Q4 2021 Results - Earnings Call Transcript
CohBar to Announce 2021 Fourth Quarter and Full-Year Financial Results and Provide Business Update on March 29, 2022
09:00am, Tuesday, 15'th Mar 2022
Company to host conference call and webcast at 5:00 p.m. ET Company to host conference call and webcast at 5:00 p.m. ET
CohBar to Present at H.C. Wainwright BIOCONNECT Conference
09:00am, Monday, 03'rd Jan 2022
MENLO PARK, Calif., Jan. 03, 2022 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company exploiting the power of the mitochondria and the peptides encoded in its genom
7 of the Best Penny Stocks Under $3 for 2022 to Buy Now
11:22am, Friday, 31'st Dec 2021
Penny stocks under $3 are full of potential and potential pitfalls. These are relatively safe and worth your consideration.
